Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
7 Federal Agencies & Big Pharma Quietly Built A Pandemic-Industrial Complex
Nearly 14 years before COVID-19, HHS created the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) and centralized federal health, biomedical, regulatory, homeland-security, and military functions around a government-directed…
Big Pharma Is Hooked on Chinese Licensing Deals
Merck & Co. executives were excited. They were working on a drug that had the potential to become a “cornerstone” treatment for cancer, with 17 late-stage trials pitting it against lung, breast and other tumors. “It is one of…
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
EDMONTON, AB, Aug. 19, 2026 /CNW/ -- Aurora Cannabis Inc. (the 'Company' or 'Aurora') (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that it has acquired Internode Pharma Limited, a…
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up?
The Invesco Pharmaceuticals ETF (PJP +1.38%) offers concentrated exposure to U.S. drugmakers, while the Invesco Nasdaq Biotechnology ETF (IBBQ +0.93%) provides a broader, lower-cost gateway to the biotechnology and pharmaceutical sectors. Both…
At DC Circ., Pharma's Latest Pricing Loss Has Silver Linings
The pharmaceutical industry's far-flung crusade against Medicare's new negotiation powers suffered a fresh setback Tuesday as the D.C. Circuit joined sister circuits in upholding the landmark pricing program, but the defeat... To view the full…
Mizuho Cuts Athira Pharma (NASDAQ:LONA) Price Target to $15.00
Athira Pharma (NASDAQ:LONA - Get Free Report) had its target price cut by investment analysts at Mizuho from $16.00 to $15.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has an 'outperform' rating on the stock.
Royalty Pharma (NASDAQ:RPRX) EVP Christopher Hite Sells 100,000 Shares of Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Christopher Hite sold 100,000 shares of the firm's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $59.97, for a total value of $5,997,000.00.
Avalyn Pharma (NASDAQ:AVLN) Sets New 1-Year High - Here's Why
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares hit a new 52-week high on Wednesday. The stock traded as high as $40.17 and last traded at $38.86, with a volume of 194791 shares. The stock had previously closed at $38.25. AVLN has been…
Commerzbank Aktiengesellschaft FI Invests $1.20 Million in Royalty Pharma PLC $RPRX
Commerzbank Aktiengesellschaft FI purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 21,407 shares…
Urogen Pharma (NASDAQ:URGN) Reaches New 1-Year High - Here's What Happened
Urogen Pharma (NASDAQ:URGN - Get Free Report) shares hit a new 52-week high on Wednesday. The stock traded as high as $49.98 and last traded at $49.5860, with a volume of 41402 shares changing hands. The stock had previously closed at $48.92. 3…
Ascendis Pharma A/S (NASDAQ:ASND) Director Jean Jacques Bienaime Purchases 2,000 Shares of Stock
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) Director Jean Jacques Bienaime purchased 2,000 shares of the company's stock in a transaction on Friday, August 14th. The stock was acquired at an average cost of $246.33 per share, for a total…
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year High - Here's What Happened
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report)'s stock price reached a new 52-week high on Wednesday. The company traded as high as $60.52 and last traded at $60.7740, with a volume of 100071 shares. The stock had previously closed at $59.69.
Pendurthi MLA seeks rehabilitation of Thadi village at the earliest
Pendurthi MLA Panchakarla Ramesh Babu has urged the State government to take immediate steps to rehabilitate and relocate residents of Thadi village in Anakapalli district, citing safety concerns due to several pharmaceutical units in and around…
Is Big Pharma Already Stalling Trump's Vaccine Executive Order?
The term is called running the clock…stalling….buying time. Splitting the measles, mumps, rubella (MMR) vaccine into separate [monovalent] shots could now take 10 years according to mainstream reporting. A decade to make a presumably…
Indian Stock Market Declines Amidst Soaring Crude Oil Prices & US-Iran Ceasefire Expiry
Indian benchmark equity indices, Sensex and Nifty, witnessed a decline in early trade as elevated crude oil prices and persistent geopolitical uncertainties, particularly the expiry of the US-Iran ceasefire, dampened investor sentiment. Indian…
Receive a Daily briefing on Pharma Industry News
Get Started